3 results
Approved WMOCompleted
The primary objective is to assess the efficacy of nemolizumab (CD14152) compared to placebo in subjects >= 18 years of age with prurigo nodularis (PN) after a 16-week treatment period.
Approved WMORecruiting
The primary objective is to assess the long-term safety of nemolizumab (CD14152) insubjects with prurigo nodularis (PN).The secondary objective is to assess the long-term efficacy of nemolizumab (CD14152)in subjects with PN
Approved WMORecruiting
Primary: To investigate the performance of the PAM3(+) device in breast cancer imaging. With the performance we mean:1. The ability to visualize blood vessels and tumors in the mammary gland (PA)2. To extract oxygenation saturation estimations (QPAT…